Disability

Braille Institute Library to Host Livestream Event with Pulitzer Prize Finalist Andrew Leland on January 16, 2025

Leland to discuss his best-selling book, “The Country of the Blind: A Memoir at the End of Sight” LOS ANGELES,…

3 days ago

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the…

3 days ago

inQUEST CEO Appointed to Access Living Board

Hoesman, Access Living to Advance Inclusion for 'Nation's Largest Minority Group' CHICAGO, Dec. 17, 2024 /PRNewswire/ -- Scott Hoesman, CEO and…

4 days ago

Large Clinical Study Finds Home-based Virtual Reality Device Creates Greater Relief for High Impact Chronic Pain Patients

Secondary analysis of a randomized, placebo-controlled study of 1,000+ participants indicated that FDA-authorized RelieVRx® yielded clinically meaningful pain intensity and pain…

4 days ago

New ALS Association-Led Research Finds Specialists Diagnose ALS Twice as Fast as General Neurologists

Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take…

2 weeks ago

VetClaims.AI Partners With The Purple Heart Foundation To Revolutionize VA Claims Support For Veterans

Collaboration Focuses on Streamlining VA Disability Claims, Expanding Veteran Support Services, and Enhancing Resources AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/…

2 weeks ago

Boland Romaine LLP is Happy to Announce the Launch of it’s New Website to Better Serve Ontario’s Residents

Redefining Advocacy for the Injured and The Unsettling Truth About SettlingTORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- In an effort…

2 weeks ago

Dr. Alexander Taghva Introduces Focused Ultrasound Treatment for Essential Tremors in Orange County, CA

Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /…

3 weeks ago

Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…

3 weeks ago

Intra-Cellular Therapies Submits Supplemental New Drug Application (sNDA) to FDA for CAPLYTA® (lumateperone) for the Treatment of Major Depressive Disorder as Adjunctive Therapy

The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTA’s robust antidepressant efficacy and favorable…

3 weeks ago